Drugs / tumor lysate-pulsed autologous dendritic cell vaccine
tumor lysate-pulsed autologous dendritic cell vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01635283 | Jan 2012 → May 2016 | adult oligodendroglioma, brain neoplasm, diffuse astrocytoma, oligoastrocytoma | Jonsson Comprehensive Cancer Center | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tumor lysate-pulsed autologous dendritic cell vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01635283 ↗ |
| Modality | Vaccine | “tumor lysate-pulsed autologous dendritic cell vaccine” NCT01635283 ↗ |